M. E. Cooper - Concepedia

Author

M. E. Cooper

The University of Melbourne

Also Known As

G. Boner, M E Cooper, M. E Cooper, M. E. Cooper, M.E Cooper, Mark E. Cooper

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

The University of Melbourne Heidelberg Repatriation Hospital Baker Heart and Diabetes Institute Austin Hospital

About

M. E. Cooper is an author at The University of Melbourne specializing in medicine, diabetes, and hypertension.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1K
2	Diabetes	4	4	871
3	Cell Biology	1	1	63
4	Cellular Physiology	1	1	63
5	Endocrinology	1	1	52

M. E. Cooper

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study C. E. Mogensen, Steen Neldam, I. Tikkanen, BMJ	2000	1K
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy B. M. Brenner, M. E. Cooper, Dick de Zeeuw ACC Current Journal Review Metabolic SyndromeHemodialysisUrologyRenal DiseaseHypertension	2002	511
Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension M. E. Cooper, Geoffrey Boner, Zemin Cao, Diabetologia Glomerular DiseaseGlomerular Nephrin ExpressionHypertensionRenal FunctionMedicine	2001	246
Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. Richard E. Gilbert, Angela Cox, Linlin Wu, Diabetes	1998	203
The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation M. E. Cooper, Vicki Thallas, Josephine M. Forbes, Diabetologia MedicineVascular PharmacologyPhysiologyGlycobiologyCross-link Breaker	2000	103
Identification of angiotensin converting enzyme 2 in the rodent retina Chris Tikellis, C. I. Johnston, Josephine M. Forbes, Current Eye Research	2004	88
Cellular Mechanisms of Diabetic Vascular Hypertrophy Dimitria Vranes, M. E. Cooper, Rodney J. Dilley Microvascular Research Cell SignalingVascular AdaptationDiabetesPhysiologyMicrovascular Dysfunction	1999	63
Effect of early menopause on bone mass in normal women and patients with qsteoporosis Ego Seeman, M. E. Cooper, John L. Hopper, The American Journal of Medicine Bone DiseaseBone HealthGynecologyBone MassEarly Menopause	1988	52
Antihypertensive therapy in a model combining spontaneous hypertension with diabetes M. E. Cooper, Jon R. Rumble, Terri J. Allen, Kidney International HypertensionDiabetes ManagementCardiovascular DiseaseAntihypertensive TherapyDiabetes	1992	51
Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure Karly C. Sourris, Jasmine G. Lyons, Sonia Dougherty, Clinical Chemistry and Laboratory Medicine (CCLM)	2013	22

Page 1